Nova director Raanan Cohen sells 2,456 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nova Ltd. director Raanan Cohen reported sales on November 10, 2026, under a Rule 10b5-1 plan: 2,456 ordinary shares at $326 per share and 665 option rights to purchase ordinary shares at $326 per share. After the transactions, the reported position was 3,595 ordinary shares, including RSUs, and 295 options. Vesting of the reported RSUs is subject to continued service.
Insider Trade Summary 10b5-1
Net Seller: 3,121 shares
Net Sell
2 txns
Insider
Cohen Raanan
Role
Director
Sold
3,121 shs ($1.02M)
Share of Position Sold
40.6%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Option (right to purchase) F5 | 665 | $326.00 | $217K |
| Sale | Ordinary Shares F1, F2, F3, F4 | 2,456 | $326.00 | $801K |
Holdings After Transaction:
Option (right to purchase) — 295 options (Direct);
Ordinary Shares — 3,595 shares (Direct)
Holdings Before and After:
Option (right to purchase), 960 to 295 options (Direct);
Ordinary Shares, 6,051 to 3,595 shares (Direct)
Footnotes (5)
- F1. Includes 2,471 ordinary shares.
- F2. Includes 426 RSUs which shall vest in equal annual installments through 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.
- F3. Includes 364 RSUs which shall vest in equal annual installments through 2028, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.
- F4. Includes 334 RSUs which 100% vest on June 18, 2027, the first anniversary of grant, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Each RSU represents the right to receive one ordinary share upon vesting and settlement.
- F5. The subject options have vested and became fully exercisable on June 24, 2025.
Key Figures
Ordinary shares sold: 2,456 shares
Sale price: $326 per share
Option rights sold: 665 option rights
+3 more
6 metrics
Ordinary shares sold
2,456 shares
November 10, 2026; at $326 per share
Sale price
$326 per share
Ordinary-share transaction on November 10, 2026
Option rights sold
665 option rights
November 10, 2026; at $326 per share
Option-right sale price
$326 per share
Option transaction on November 10, 2026
Ordinary shares reported after transaction
3,595 shares
Post-transaction amount includes RSUs
Options reported after transaction
295 options
Post-transaction position
Key Terms
Rule 10b5-1 plan, RSUs, fully exercisable
3 terms
Rule 10b5-1 plan regulatory
"the transactions were reported under a Rule 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
RSUs financial
"the reported ordinary-share amount includes RSUs"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
fully exercisable technical
"the options became fully exercisable on June 24, 2025"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many NVMI options did Raanan Cohen sell, and how many remained?
Cohen reported selling 665 option rights at $326 per share on November 10, 2026, with 295 options remaining afterward. The options had become fully exercisable on June 24, 2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.
